Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum Chemotherapy
Year: 2025
Type: article
Source: Journal of Medicinal Chemistry
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Irish Research Council
Award: G1207506227
OpenAlex ID: W4416082555
